Zhu H, Zheng M, He H, Lei H, Tai W, Yang J
Sci Rep. 2024; 14(1):31369.
PMID: 39732944
PMC: 11682153.
DOI: 10.1038/s41598-024-82854-1.
Yu H, Lv T, Li S, Chen S, Li M, Liu J
Am J Surg Pathol. 2024; 49(3):265-272.
PMID: 39704223
PMC: 11834957.
DOI: 10.1097/PAS.0000000000002343.
Shi H, Wang Q, Liu H, Xu B, Liu Y, Zhao J
Open Life Sci. 2024; 19(1):20220979.
PMID: 39588121
PMC: 11588006.
DOI: 10.1515/biol-2022-0979.
Shi H, Xu X, Wang S, Chen Q, Zhang F, Guo H
Hepatol Int. 2024; 18(5):1555-1565.
PMID: 39134906
DOI: 10.1007/s12072-024-10715-0.
Li M, Chen S, Li S, Lv T, Li B, Shan S
Therap Adv Gastroenterol. 2024; 17:17562848231224840.
PMID: 38250015
PMC: 10798075.
DOI: 10.1177/17562848231224840.
Autotaxin: A Potential biomarker for primary biliary cholangitis.
Yang Y, Liu B, Zang B, Liu Q, Zhao C, Yao Y
Heliyon. 2024; 10(1):e23438.
PMID: 38173498
PMC: 10761557.
DOI: 10.1016/j.heliyon.2023.e23438.
The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC).
Cylwik B, Bauer A, Gruszewska E, Gan K, Kazberuk M, Chrostek L
J Clin Med. 2023; 12(24).
PMID: 38137620
PMC: 10743606.
DOI: 10.3390/jcm12247552.
CT and MR imaging of primary biliary cholangitis: a pictorial review.
Zhang Y, Zheng T, Huang Z, Song B
Insights Imaging. 2023; 14(1):180.
PMID: 37880457
PMC: 10600092.
DOI: 10.1186/s13244-023-01517-3.
Total and individual PBC-40 scores are reliable for the assessment of health-related quality of life in Greek patients with primary biliary cholangitis.
Rigopoulou E, Bakarozi M, Dimas I, Galanis K, Lygoura V, Gatselis N
J Transl Int Med. 2023; 11(3):246-254.
PMID: 37818155
PMC: 10561069.
DOI: 10.2478/jtim-2023-0098.
Liver transplant in primary sclerosing cholangitis: Current trends and future directions.
Shah Y, Nombera-Aznaran N, Guevara-Lazo D, Calderon-Martinez E, Tiwari A, Kanumilli S
World J Hepatol. 2023; 15(8):939-953.
PMID: 37701917
PMC: 10494561.
DOI: 10.4254/wjh.v15.i8.939.
Risk Stratification in Primary Biliary Cholangitis.
Martini F, Balducci D, Mancinelli M, Buzzanca V, Fracchia E, Tarantino G
J Clin Med. 2023; 12(17).
PMID: 37685780
PMC: 10488776.
DOI: 10.3390/jcm12175713.
Prevalence and risk factors of osteoporosis detected by dual-energy X-ray absorptiometry among Chinese patients with primary biliary cholangitis.
Chen J, Liu Y, Bi Y, Wang X
World J Gastroenterol. 2023; 29(29):4580-4592.
PMID: 37621753
PMC: 10445004.
DOI: 10.3748/wjg.v29.i29.4580.
Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct Syndrome.
Lv T, Yu H, Han X, Wee A, Liu J, Li M
J Clin Transl Hepatol. 2023; 11(5):1161-1169.
PMID: 37577216
PMC: 10412695.
DOI: 10.14218/JCTH.2022.00039.
Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis.
Staufer K, Huber H, Zessner-Spitzenberg J, Stauber R, Finkenstedt A, Bantel H
Cell Death Discov. 2023; 9(1):282.
PMID: 37532736
PMC: 10397215.
DOI: 10.1038/s41420-023-01551-6.
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).
You H, Duan W, Li S, Lv T, Chen S, Lu L
J Clin Transl Hepatol. 2023; 11(3):736-746.
PMID: 36969891
PMC: 10037524.
DOI: 10.14218/JCTH.2022.00347.
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis.
Trauner M, Chung C, Sterling K, Liu X, Lu X, Xu J
BMC Gastroenterol. 2023; 23(1):75.
PMID: 36922785
PMC: 10015541.
DOI: 10.1186/s12876-023-02653-2.
Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases.
Nagata T, Takeyama Y, Shakado S, Hirai F, Nimura S
Cureus. 2023; 15(1):e34275.
PMID: 36855497
PMC: 9968480.
DOI: 10.7759/cureus.34275.
Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation.
Wang H, Zhang J, Liu J, Jiang Y, Fu L, Peng S
Front Mol Biosci. 2023; 10:1124956.
PMID: 36845547
PMC: 9947156.
DOI: 10.3389/fmolb.2023.1124956.
Unique DUOX2ACE2 small cholangiocytes are pathogenic targets for primary biliary cholangitis.
Li X, Li Y, Xiao J, Wang H, Guo Y, Mao X
Nat Commun. 2023; 14(1):29.
PMID: 36759512
PMC: 9911648.
DOI: 10.1038/s41467-022-34606-w.
Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China.
Zhao D, Yan H, Liao H, Liu Y, Han Y, Zhang H
Front Immunol. 2023; 13:1098076.
PMID: 36685575
PMC: 9845730.
DOI: 10.3389/fimmu.2022.1098076.
